PatiententagAn Interactive Survivor Symposium with Focus on Quality of Life
09:30 – 10:30
Room: Großer Saal
Scientific SessionThe HL Stem Cell
Bernd Dörken
Randy Gascoyne
Leukaemic Stem Cells: AML Show the Way
Dominique Bonnet
Cancer Stem Cells in Hodgkin Lymphoma
Richard Ambinder
Aspects of the Relationship of Hodgkin and Reed/Sternberg Cells and Potential Precursor Cells
Ralf Küppers
10:30 – 12:00
Room: Großer Saal
Scientific SessionLymphoma Microenvironment
Margaret Shipp
Harald Stein
Classical Hodgkin Lymphoma Micro- environment. Pathologic Aspects and the Role of CD40 / CD40L
Antonio Carbone
Gene and Micro-RNAs Signatures as Predictors of Risk in Hodgkin Lymphoma: Integrating Tumor and Microenvironment
Juan F García
Can Immunohistochemical Markers at Diagnosis Have the Same Predictive Value of Early Interim-PET in Classical Hodgkin Lymphoma?
Stefano Pileri
Integrative Analysis Reveals Selective 9p24.1 Ampli cation, Increased PD-L1 Ligand Expression and Further Induction via JAK2 in Nodular Sclerosing Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Margaret Shipp
12:15 – 13:30
Room: Großer Saal
Satellite SymposiumLenalidomide in Lymphoma – Latest Update on Clinical Data
Volker Diehl
Rational and Clinical Experiences with Lenalidomide in Hodgkin Lymphoma
Boris Böll
Progress in CLL Treatment
Clemens Wendtner
Emerging Treatment Options for Mantle Cell Lymphoma
Marek Trnĕný
14:00 – 15:00
Room: Großer Saal
Satellite SymposiumCD30 as a Target for Hodgkin Lymphoma
Andreas Engert
Welcome and Introduction
Andreas Engert
Clinical Gaps in the Treatment of Patients with Relapsed/Refractory Hodgkin Lymphoma
Peter Johnson
Targeting CD30 in Hodgkin Lymphoma
Andreas Engert
Ongoing Phase III Trials in Relapsed/Refractory Hodgkin Lymphoma
Pauline Brice
Panel Discussion: Optimizing the Path to Transplant for Patients with Late-Stage Hodgkin Lymphoma
Pauline Brice
Andreas Engert
Peter Johnson
16:00 – 17:30
Room: Großer Saal
Satellite SymposiumNovel Approaches in the Treatment of Hodgkin Lymphoma: Beyond Chemotherapy
Andreas Engert
Welcome and Introduction
Andreas Engert
DAC Inhibitors, a New Class of Compounds: Landscape and MOA
Anas Younes
Evolution of Panobinostat in Treating Hodgkin Lymphoma
Franck Morschhauser
Novartis Pipeline: Investigational Compounds in Lymphoma
Patrick Johnston
New Products (LBH)
Anas Younes
Summary and Close
Andreas Engert
18:00 – 20:00
Room: Großer Saal
Main ProgramOpening Ceremony
Bonadonna Lecture: The Role of Viral Infections in Hodgkin Lymphoma